Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study

Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, Anastasia Shikhaleva, Aysylu Gamirova, Oleg Blyuss, Nikita Nekliudov, Polina Bugaeva, Margarita Andreeva, Audrey DunnGalvin, Pasquale Comberiati, Christian Apfelbacher, Jon Genuneit, Sergey Avdeev, Valentina Kapustina, Alla Guekht, Victor Fomin, Andrey A Svistunov, Peter Timashev, Thomas M Drake, Sarah Wulf Hanson, Laura Merson, Peter Horby, Louise Sigfrid, Janet T Scott, Malcolm G Semple, John O Warner, Theo Vos, Piero Olliaro, Petr Glybochko, Denis Butnaru, Sechenov StopCOVID Research Team
doi: https://doi.org/10.1101/2021.02.17.21251895

Article Information

doi 
https://doi.org/10.1101/2021.02.17.21251895
History 
  • February 19, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Daniel Munblit1,2,3,*,†,
  2. Polina Bobkova1,*,
  3. Ekaterina Spiridonova1,*,
  4. Anastasia Shikhaleva1,*,
  5. Aysylu Gamirova1,*,
  6. Oleg Blyuss1,4,*,
  7. Nikita Nekliudov1,
  8. Polina Bugaeva1,
  9. Margarita Andreeva1,
  10. Audrey DunnGalvin1,5,
  11. Pasquale Comberiati6,
  12. Christian Apfelbacher7,
  13. Jon Genuneit8,
  14. Sergey Avdeev9,
  15. Valentina Kapustina10,
  16. Alla Guekht3,
  17. Victor Fomin11,
  18. Andrey A Svistunov11,
  19. Peter Timashev12,
  20. Thomas M Drake13,
  21. Sarah Wulf Hanson14,
  22. Laura Merson15,
  23. Peter Horby15,
  24. Louise Sigfrid15,
  25. Janet T Scott16,
  26. Malcolm G Semple17,18,
  27. John O Warner2,
  28. Theo Vos14,
  29. Piero Olliaro15,
  30. Petr Glybochko11,
  31. Denis Butnaru11,
  32. Sechenov StopCOVID Research Team
  1. 1Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
  2. 2Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
  3. 3Research and Clinical Center for Neuropsychiatry, Moscow, Russia
  4. 4School of Physics, Astronomy and Mathematics, University of Hertfordshire, College Lane, Hatfield, United Kingdom
  5. 5School of Applied Psychology, University College Cork, Cork City, Ireland
  6. 6Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy
  7. 7Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany
  8. 8Pediatric Epidemiology, Department of Pediatrics, Medical Faculty, Leipzig University, Leipzig, Germany
  9. 9Clinic of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
  10. 10Department of Internal Medicine №1, Institute of Clinical Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
  11. 11Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
  12. 12Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
  13. 13Centre for Medical Informatics, University of Edinburgh, Edinburgh, UK
  14. 14Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
  15. 15ISARIC Global Support Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  16. 16MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
  17. 17Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
  18. 18Department of Respiratory Medicine, Alder Hey Children’s Hospital, Liverpool, UK
  1. ↵†Corresponding author:
    Daniel Munblit, MD, PhD. Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia and Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom, Email: daniel.munblit08{at}imperial.ac.uk
    1. 1Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

    1. ↵* Authors contributed equally to the paper.

    Back to top
    Posted February 19, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email
    Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study
    Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, Anastasia Shikhaleva, Aysylu Gamirova, Oleg Blyuss, Nikita Nekliudov, Polina Bugaeva, Margarita Andreeva, Audrey DunnGalvin, Pasquale Comberiati, Christian Apfelbacher, Jon Genuneit, Sergey Avdeev, Valentina Kapustina, Alla Guekht, Victor Fomin, Andrey A Svistunov, Peter Timashev, Thomas M Drake, Sarah Wulf Hanson, Laura Merson, Peter Horby, Louise Sigfrid, Janet T Scott, Malcolm G Semple, John O Warner, Theo Vos, Piero Olliaro, Petr Glybochko, Denis Butnaru, Sechenov StopCOVID Research Team
    medRxiv 2021.02.17.21251895; doi: https://doi.org/10.1101/2021.02.17.21251895
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools

    Subject Area